Drug Shortage Report for ULTRAVIST 300
Report ID | 224122 |
Drug Identification Number | 02078600 |
Brand name | ULTRAVIST 300 |
Common or Proper name | IOPROMIDE |
Company Name | BAYER INC |
Market Status | MARKETED |
Active Ingredient(s) | IOPROMIDE |
Strength(s) | 62% |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVASCULAR INTRAVASCULAR |
Packaging size | 100mL |
ATC code | V08AB |
ATC description | X-RAY CONTRAST MEDIA, IODINATED |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-02-15 |
Actual start date | 2024-01-29 |
Estimated end date | 2024-09-06 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-04-02 | French | Compare |
v3 | 2024-04-02 | English | Compare |
v2 | 2024-04-02 | French | Compare |
v1 | 2024-04-02 | English | Compare |
Showing 1 to 4 of 4